PARP Inhibition in the Treatment of Pancreatic Cancer: Current and Future Perspectives on Personalized Therapy

Download All
Learn how experts around the world use PARP inhibitors to optimally manage patients with pancreatic cancer and BRCA1/2 or other alterations causing homologous repair deficiency with focused commentaries, a podcast series, an expert video roundtable, and downloadable slideset.
Dirk Arnold, MD, PhD
person default
Michel Ducreux, MD, PhD
Philip Agop Philip, MD, PhD, FRCP

Expert Video Roundtable

In this video roundtable, watch 3 experts give their perspectives on the optimal management of patients with pancreatic cancer using PARP inhibitors, as well as emerging strategies with PARP inhibitors that they find promising.

Download this slideset on the current advances and evolving landscape of PARP inhibitors for patients with pancreatic cancer.

Dirk Arnold, MD, PhD person default Michel Ducreux, MD, PhD Philip Agop Philip, MD, PhD, FRCP Released: December 14, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings